Username Password
S&P 500: 1,351.68 Change: +0.14%

DENDREON CP (DNDN)

Overview
Price 14.78
Price Change Today -$0.49 (-3.21%)
P&P rating Rating: 2
Zacks Rank 3 - HOLD
Open Price $15.20
Previous Close $15.27
Daily Range $14.61 - $15.38
52-Week Range $6.46 - $43.96
Volume 9,520,277
chart
Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. Through the use of antigen engineering and proprietary cell separation technologies, Dendreon develops therapeutic vaccines that induce cell-mediated immunity, the body's key defense against cancer. In addition to its products for cancer, Dendreon also intends to pursue the application of its technologies in the fields of autoimmune diseases, allergies and infectious diseases.
Other Resources for DNDN
zacks.com
Commentary
Zacks Blog: Dendreon Gets a New CEO
February 2, 2012
Zacks Blog: Company News for February 2, 2012
February 2, 2012
Zacks Blog: Dendreon Stays Neutral
January 24, 2012
Zacks Blog: Pleasant Surprise for Dendreon
January 9, 2012
Zacks Blog: Company News for January 06, 2012
January 6, 2012
Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. Through the use of antigen engineering and proprietary cell separation technologies, Dendreon develops therapeutic vaccines that induce cell-mediated immunity, the body's key defense against cancer. In addition to its products for cancer, Dendreon also intends to pursue the application of its technologies in the fields of autoimmune diseases, allergies and infectious diseases.
 
Brokerage Analyst Recommendations
20 Brokerage Firms Covering DNDN
 
   
Strong Buy
6
Buy
0
Hold
11
Sell
0
Strong Sell
3
Average Broker Recommendation (ABR): 2.7
 
DNDN Ratings:BUY  SELL  HOLD
DNDN Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

157 Buy
15 Sell
 
Top Buy Analysis
BUY: DNDN Rating: 2
Company: DENDREON CORPORATION
Points: 67.07
Start Price: $6.37
Start Date: 04/07/2009 10:38 PM
ladyfriend2
ladyfriend2
P&P Score: 99.63
Recs:
NOW is the time to buy in this! No analysis, just an urgent desicion.

Comments: 0 | Comment


Top Sell Analysis
SELL: DNDN Rating: 2
Company: DENDREON CORPORATION
Points: 84.91
Start Price: $21.20
Start Date: 04/30/2009 3:33 PM
ChrisCringle
ChrisCringle
P&P Score: 98.79
Recs:

Comments: 0 | Comment

Blog Posts
User User Score Date Title Comments Last Comment
profit55
99.89 10/28/11 Pleez, sheeple, ....3J the lunatic needs yer hep with margin calls 7 10/28/11
rjm77me
99.92 10/13/11 Ignorant Just Joe the fumbling clown lost COOL 1/2 MILLION IN HIS 5100 CLOSED TRADES = My points were never in minus since day 1 on this web site 5 10/27/11
rjm77me
99.92 08/05/11 DNDN IS OK AS TRADE - Not as investment 5 08/09/11
rjm77me
99.92 08/03/11 SOME folks were giving HI FIVE for some ones misery Reference DNDN 12 08/05/11
rjm77me
99.92 08/03/11 Breaking News DNDN plunges $20 after hours TO 14.50 6 08/04/11
MightyMo
99.78 07/01/11 DNDN GETS APPROVALS ! 1 11/03/11
TheHammer
72.80 01/07/11 DNDN-all fluff or the real deal? 3 01/11/11
MightyMo
99.78 11/25/10 #2: Diversified top ten stocks 4 03/07/11
MightyMo
99.78 07/07/10 DNDN: Dendreon - Fear is Our Friend 76 08/03/11
zantriocom
0.00 07/01/10 Zantrio.com Free Daily Stock Picks 7-1-2010 0
Pages: [ 1 ]  2   3   4   5   6   7  >>
Commentary
BUY: DENDREON CORPORATION (DNDN) Rating: 2
Start Price: $11.65
Points: +11.45
Created: 09/21/2011
Trading at a bargain price.
Very bad marketing and i believe the strategy has changed we shall soon here about, that would lift pps to 15$ at first, then 20$ in 4-6 months.

My Target is 20$ in the short term.

Comments: 0 | Comment

Recs:
 
BUY: DENDREON CORPORATION (DNDN) Rating: 2
Start Price: $41.40
Points: -65.08
Created: 07/01/2011
Turning up from correction

Comments: 0 | Comment

Recs:
 
BUY: DENDREON CORPORATION (DNDN) Rating: 2
Start Price: $33.48
Points: -59.18
Created: 03/01/2011
Great potencial Pharma stock

Comments: 0 | Comment

Recs:
 
BUY: DENDREON CORPORATION (DNDN) Rating: 2
Start Price: $37.82
Points: -71.44
Created: 12/02/2010
definitely buy.

Comments: 0 | Comment

Recs:
 
BUY: DENDREON CORPORATION (DNDN) Rating: 2
Start Price: $35.30
Points: -76.69
Created: 03/07/2010
It has shown many strength,

Comments: 0 | Comment

Recs:
 
BUY: DENDREON CORPORATION (DNDN) Rating: 2
Start Price: $35.30
Points: -76.69
Created: 03/05/2010
good gainer

Comments: 0 | Comment

Recs:
 
BUY: DENDREON CORPORATION (DNDN) Rating: 2
Start Price: $34.85
Points: -78.26
Created: 03/03/2010
I picked up this stock in the fall, 2009 when it was @ $9.00. I sold it at $23 last year, despite listening to a guy tell me back then it was going to settle in at +/- $40.00, in the spring.

Originally, my order was scheduled to go in @ $5, but (my luck) DNDN stopped trading for almost 3 hours, due to 'trader irregularities!' The original order did not go through. Had the stock tanked, no doubt it would have gone through.

I again picked up DNDN at $28. At $25, DNDN seemed to receive increased daily volume and options action. Now that it has moved past $30 and has held there, I believe the guy who said it would reach $40, either was lucky or really knew, It may take awhile, but if the drug they are producing (a prostate cancer retardant?), receives FDA approval, it will zoom past $60 almost overnight.

I am not a 'WOW' person, but this may be as close as it gets.

Comments: 0 | Comment

Recs:
 
BUY: DENDREON CORPORATION (DNDN) Rating: 2
Start Price: $27.24
Points: -69.40
Created: 11/28/2009
huge cancer therapy very positive

Comments: 0 | Comment

Recs:
 
BUY: DENDREON CORPORATION (DNDN) Rating: 2
Start Price: $24.27
Points: -77.51
Created: 07/29/2009
DNDN is working to get everything that FDA will require to have their prostate drug approved. Before they ask for drug certification dndn will have the cash,factory and employees ready to start production..

Comments: 0 | Comment

Recs:
 
BUY: DENDREON CORPORATION (DNDN) Rating: 2
Start Price: $23.42
Points: -80.04
Created: 05/30/2009
Easy double or even triple.New prostate cancer drug has2-3 billion $ per year sales potential.Also company maybe takeover target for big pharma cos.

Comments: 1 | Comment

Recs:
 
Pages: [ 1 ]  2   3   4   5   ...  18  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
MightyMo 99.78 BUY Week or Less 02/06/2012 $15.96 $14.83
(-2.95%)
-7.08% +0.34% -7.42 view
uptensweet 99.99 BUY One to Three Months 11/26/2011 $7.85 $14.83
(-2.95%)
+88.92% +16.66% +72.26
Yade 99.88 BUY One to Three Years 11/09/2011 $7.27 $14.83
(-2.95%)
+103.99% +9.97% +94.02 view
TomBarrett007 4.51 BUY Six Months to a Year 09/21/2011 $11.65 $14.83
(-2.95%)
+27.30% +15.85% +11.45 view
wallstreeter 0.23 BUY Six Months to a Year 07/01/2011 $41.40 $14.83
(-2.95%)
-64.18% +0.90% -65.08 view
hofmann 2.38 BUY Week or Less 03/01/2011 $33.48 $14.83
(-2.95%)
-55.70% +3.47% -59.18 view
hoeboi 2.07 BUY Week to a Month 12/02/2010 $37.82 $14.83
(-2.95%)
-60.79% +10.65% -71.44 view
jandonieh BUY Six Months to a Year 03/07/2010 $35.30 $14.83
(-2.95%)
-57.99% +18.70% -76.69 view
Kenneth_Jezewski 2.42 BUY Week to a Month 03/05/2010 $35.30 $14.83
(-2.95%)
-57.99% +18.70% -76.69 view
seagate5 BUY Three to Six Months 03/03/2010 $34.85 $14.83
(-2.95%)
-57.45% +20.82% -78.26 view
Pages: [ 1 ]  2   3   4   5   ...  18  >>
Sponsored Links